Vice President Yemi Osinbajo (SAN) has stated that the presidency remains committed to finding a vaccine for the Novel Coronavirus (COVID-19).
According to a statement issued by the Senior Special Assistant to the President on Media and Publicity, Office of the Vice President, Mr. Laolu Akande, Osinbajo disclosed this on Wednesday during a virtual meeting with representatives of the BNT162 COVID-19 vaccine candidate on the progress of the vaccine development around the world, including Africa.
The Vice President said: “Our priority is the health of the Nigerian citizens. We continue to engage and intend to look at every possible option -from all manufacturers- of a good vaccine. We want to do the very best for our people in this regard.”
Responding, the Pfizer Country Manager and Representative in Africa, who spoke for the promoters, Mr. Subair Olayinka, promised that “Nigeria will be priority” for the vaccine supply to Africa.
The meeting was attended by the Health Minister, Dr. Osagie Ehanire and the Executive Director of the National Primary Health Care Development Agency, Dr. Faisal Shuaib, with representatives of Pfizer and Biotech, the international pharmaceutical firms promoting the BNT162 vaccine candidate.